Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HHS/DoJ WOULD ISSUE "ADVISORY OPINIONS" ON LEGALITY OF SUPPLIER-PROVIDER DEALS UNDER INSURANCE REFORM MEASURE; RISK-SHARING PROTECTION ALSO INCLUDED

This article was originally published in The Gray Sheet

Executive Summary

Health care-suppliers and providers could receive federal "advisory opinions" on the legality of their business arrangements under an anti-fraud provision in the health insurance reform legislation (HR 3103) reported out of a House/Senate conference committee July 31. The bill was adopted by the House on Aug. 1, followed by the Senate on Aug. 2.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT006458

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel